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Selvage, Daniel J., Ph.D., February, 2001 Pharmaceutical Sciences
Central Neurochemical Mechanisms Involved in the Generation of the Preovulatory 
GnRH Surge in Normally Cycling Proestrous Female Rats
A number o f central neurotransmitters have been implicated in the cyclic control of 
gonadotropin-releasing hormone (GnRH) secretion from the median eminence (ME) of 
the basal hypothalamus (BH) in normally cycling female rats. The large surge of this 
hormone released on the afternoon of proestrus stimulates secretion o f luteinizing 
hormone (LH) from the pituitary, thereby driving ovulation. Among the central 
neurotransmitters thought to play a stimulatory role in the preovulatory, proestrous 
release of GnRH are norepinephrine (NE), oxytocin (OT), and nitric oxide (NO). The 
purpose of this research was to investigate the role of these neurotransmitters in 
stimulating GnRH release from BH explants in vitro, in order to better understand how 
they may be working in vivo.
It was found that OT stimulated GnRH release from BH explants, but not ME 
fragments harvested on the afternoon of proestrus from normally cycling female rats. 
This suggests that the connectivity o f  the intact BH is required for OT to stimulate 
proestrous GnRH release. The ability o f OT to stimulate proestrous GnRH release from 
BH explants was blocked by OT receptor antagonism, and by NO synthase (NOS) 
inhibition. NE was also found to stimulate GnRH release from proestrous BH explants. 
Alpha-1, but not alpha-2 adrenergic receptor antagonism blocked the ability of NE to 
stimulate proestrous GnRH release from BH explants. OT receptor antagonism 
attenuated, but did not entirely block the effect of NE on GnRH release. When used in 
combination, NE/OT synergistically stimulated GnRH release from proestrous BH 
explants. This is the first report of this effect. NE/OT- induced stimulation o f proestrous 
GnRH release from BH explants was blocked by OT receptor antagonism, and by 
inhibition of NOS. The results suggest that combined NE/OT stimulate GnRH release 
from proestrous BH explants in a synergistic manner, using OT- receptor and NO 
mediated mechanisms.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Committee Chairman: Craig A. Johnston
u
Table of Contents
Chapter 1: Introduction Page
Introduction..........................................................................................................1
Gonadal steroids and the estrous cycle ............................................................ 2
Luteinizing hormone and ovulation...................................................................3
GnRH................................................................................................................... 4
Control o f GnRH release.....................................................................................6
Norepinephrine.................................................................................................... 8
Oxytocin............................................................................................................. 10
Nitric Oxide........................................................................................................12
Interaction between the OT, NE, and NO
neurotransmitter systems on reproductive behaviors..................................... 14
Specific aims..................................................................................................... 20
C hapter 2: Materials and Methods
Animals..............................................................................................................22
Tissue preparation.............................................................................................23
Lowry protein assay..........................................................................................24
Radioimmunoassy.............................................................................................25
Measurement of nitric oxide: the griess reaction........................................... 28
Statistics.............................................................................................................30
C hapter 3: Results
OT stimulates GnRH release from proestrous BH
but not ME....................................................................................................... 35
OT stimulation of proestrous GnRH release: Mechanisms o f
action.................................................................................................................. 38
NE stimulates GnRH release on the afternoon of proestrous........................ 45
Interactions between NE and OT in stimulating GnRH release
in vitro................................................................................................................ 51
OT and NE stimulation of NO: mechanisms of action and
similarities to GnRH stimulation.....................................................................58
Effect o f OT, NE, and NE/OT on GnRH and NO release from
diestrous and estrous explants.......................................................................... 62
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 4: Discussion
Introduction....................................................................................................... 67
Stimulation of proestrous GnRH and NO release.......................................... 68
Stimulation of GnRH and NO on estrus and diestrus.................................... 76
Model of mechanisms of action o f NE and OT on the
stimulation of GnRH........................................................................................ 77
Future directions................................................................................................79
Summary and conclusions................................................................................ 82
Bibliography.................................................................................................... 85
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Tables and Figures 
Chapter 1 Page
Figure 1-1. Schematic of events involved in ovulation.................................. 16
Figure 1-2. Hormone secretion levels throughout the estrous cycle 17-18
Table 1-1. Agents stimulatory and inhibitory to GnRH................................. 19
Chapter 2
Table 2-1. GnRH peptide dilution series........................................................ 26
Table 2-2. Peparation o f standard nitrate/nitrite curve.................................. 28
Figure 2-1. Vaginal cytology on metestrus.................................................... 31
Figure 2-2. Vaginal cytology on diestrus....................................................... 32
Figure 2-3. Vaginal cytology on proestrus..................................................... 33
Figure 2-4. Vaginal cytology on estrus...........................................................34
Chapter 3
Figure 3-1. OT- induced stimulation of GnRH from
the ME versus the BH......................................................................................36
Figure 3-2. Dose-response curve for OT- stimulation of GnRH release 
from proestrous BH.........................................................................................37
Figure 3-3. Effect of kainite receptor antagonism on OT-
induced GnrH release from proestrous BH..................................................40
Figure 3-4. Effect of alpha-1 adrenergic antagonism on OT-
induced GnRH release from proestrous BH.................................................. 41
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Tables and Figures (continued)
Figure 3-5. Effect of alpha-2 adrenergic antagonism on OT-
Induced GnRH release from proestrous BH...................................................42
Figure 3-6. Effect o f NOS inhibition on OT- induced GnRH release 
from proestous BH............................................................................................ 43
Figure 3-7. Effect of OT- receptor antagonism on OT- induced
GnRH form proestrous BH..............................................................................44
Figure 3-8. Dose-response curve forNE- induced stimulation
of GnRH release from proestrous BH............................................................. 47
Figure 3-9. Effect o f alpha-1 adrenergic antagonism on NE- induced 
GnRH release from proestrous BH................................................................. 48
Figure 3-10. Effect o f alpha-2 adrenergic antagonism on NE- induced 
GnRH release from proestrous BH................................................................. 49
Figure 3-11. Effect o f OT- receptor antagonism on NE- induced
GnRH release from proestrous BH................................................................. 50
Figure 3-12. Effect o f OT and/or NE
on GnRH release from proestrous BH............................................................ 53
Figure 3-13. Effect o f NOS antagonism on NE/OT- induced GnRH 
release from proestrous BH.............................................................................. 54
Figure 3-14. Effect if administration of an OT- receptor antagonist on 
combined NE/OT- induced stimulation of GnRH from proestrous BH 55
Figure 3-15. Effect of alpha-1 adrenergic antagonism on the stimulation 
of GnRH from proestrous BH by the combination of NE and OT...............56
Figure 3-16. Effect o f adrenergic alpha-2 antagonim on the stimulation 
Of GnRH from proestrous BH by the combination of NE and OT..............57
Figure 3-17. Effect o f NE, OT, or their combination, on NO
synthesis in proestrous BH............................................................................... 59
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Tables and Figures (continued)
Figure 3-18. Effect of addition of an OT- receptor antagonist on 
stimulation o f proestrous NO synthesis by NE, OT, or their combination...60
Figure 3-19. Comparison o f NO and GnRH stimulation from
proestrous BH................................................................................................... 61
Figure 3-20. Effect of OT, NE, or their combination on diestrus,
estrus, and proestrus GnRH release................................................................ 64
Figure 3-21. Effect of OT, NE, or their combination on diestrus,
estrus, and proestrus NO synthesis and release..............................................65
Table 3-1. Summary of GnRH and NO stimulation from BH explants 
by NE and/or OT on the afternoons of proestrus, estrus, and diestrus.........66
Chapter 4
Figure 4-1. Proposed model of events involved in the generation of
the proestrous GnRH surge.............................................................................. 78
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Abbreviations
AVP.................arginine vasopressin
CNOS............. constitiuative nitric oxide synthase
CNS.................central nervous system
CRF................  corticotropin releasing factor
DAG...............  diacylglycerol
FSH................  follicle stimulating hormone
GAB A............  y-aminobutyric acid
GnRH.............  gonadotropin-releasing hormone
ICC................. immunocytochemistry
ICV................. intraventricular cannula
IEG................  immediate early gene
IP3................  1,4,5-tris-phosphate
KRBG  krebs ringer buffer
LH.................  luteinizing hormone
LHRH............  lutienizing hormone-releasing hormone
LNAME  N-nitro-L-arginine methyl ester
MBH............... medialbasal hypothalamus
ME.................  median eminence
MPO...............  medial preoptic area
NBQX  kainate receptor antagonist (trade name)
NE.................  norepinephrine
nNOS  neuronal nitric oxide synthase
NO.................  nitric oxide
NOS.................nitric oxide synthase
NPY.................neuropeptide Y
ODQ...............  1 H-( 1,2,4)oxadiazolo(4,3 a)quinoxalin-1 -one
OT....................oxytocin
OTA.................oxytocin receptor antagonist [d(CH2)5, Tyr (Me)2, ORN8] vasotocin
OVLT............. organum vasculosom of the lamina terminalis
OVX...............  ovariectomized
POA................ preoptic area
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Abbreviations (continued)
PRZ...............  prazosin
PVN................  paraventricular nucleus
RH.................  rostral hypothalamus
SON................  supraoptic nucleus
VMN.................ventromedial nucleus
YO................... yohimbine
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Acknowledgements
A number of people made large contributions to the work presented in this 
dissertation. Foremost among them I would like to thank Craig Johnston, who introduced 
me to the subject of neuroendocrinology, patiently advised and mentored me as my 
research progressed, and always encouraged me to strive for excellence. I would also like 
to express my gratitude for the contribution of Vernon Grund, who opened the door for 
me to do my PhD at the University of Montana, and who played an important role during 
my time here as a committee member, and as Department Chairmen and Graduate 
Student Advisor. I would also like to thank my other committee members, Diana Lurie, 
Keith Parker, and Brent Ruby, whose advice and ideas contributed greatly to this work. 
Others who contributed to this work include the faculty of the department of 
Phamaceutical Sciences, nearly all o f who went out of their way to help me in some 
manner over the years, and my fellow students (past and present), most notably ‘Uncle’ 
Bret Bessac, Travis Denton, and Celine Wishcamper. Finally, E would like to thank my 
parents, Toby and Carlene Armstrong, and especially my wife, Mei Yang Selvage. Their 
love and support made the completion of this project possible.
x
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1
Chapter 1: Introduction
Scientists have studied the control o f reproductive cycles since the discovery and 
characterization of the gonadal endocrine steroids, estradiol and progesterone, in the 
1930’s. In the late 1940’s and early 1950’s, connections between the brain and the 
pituitary were elucidated, and the field of neuroendocrinology founded (Harris 1955; 
Bargmann and Scarrer 1951). In 1955, the possibility that the brain controls anterior 
pituitary gland function via the hypothalamic hypophysial portal blood system was first 
suggested (Harris 1955). Central nervous system (CNS) regulation o f fertility-related 
pituitary function was first shown when Kalra (1971) demonstrated that electrochemical 
stimulation of the medial preoptic area (MPO) of the hypothalamus evoked the release of 
luteinizing hormone (LH), which drives ovulation, from the pituitary gland. In the early 
1970’s it was demonstrated that CNS-controlled pituitary function depended on 
circulating levels o f estradiol and progesterone produced by the ovaries (Tepperman 
1980), and the primary hypothalamic LH-releasing factor, gonadotropin-releasing 
hormone (GnRH), was characterized (Schally et al. 1972; Yen and JafFe 1986). Since that 
time, the effect of many endogenous CNS neurotransmitter systems on GnRH release and 
fertility cycles have been described, but a clear picture of how the brain controls these 
cycles has not been determined. Also unresolved is how the peripheral endocrine system 
signals the brain that the peripheral reproductive organs are prepared for ovulation, and 
the timing for the preovulatory surge o f LH is perfect. Figure 1-1 summarizes the 
feedback loops involved in the generation o f the preovulatory GnRH surge and ovulation.
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Regulation of Fertility: Gonadal Steroids and the Estrous Cycle
Because of its overall physiological similarity to the human and short estrous 
cycle, the rat is frequently used as a model for studying female fertility. Rats have a four 
to five day estrous cycle, which is characterized by cyclically changing hormone levels 
(Figure 1-2), and corresponding changes in vaginal cytology. The first day o f the cycle is 
called metestrus (or diestrus one). Reproduction-specific gonadal and hypothalamic 
hormone levels remain low during metestrus. The second day of the cycle is diestrus (or 
diestrus two). Hormone levels remain quiescent until very late in diestrus, when estradiol 
levels slowly begin to rise. During proestrus, the third day of the cycle, estradiol levels 
continue to rise, reaching a peak in the late afternoon. On the afternoon of proestrus, 
progesterone levels also rapidly rise. The timing of the increases in these two gonadal 
hormones (especially estradiol), in turn, somehow signals the hypothalamus to secrete a 
large pulse of the hypothalamic hormone, GnRH, from the median eminence (ME). This 
hypothalamic hormone stimulates the preovulatory surge of LH release from the anterior 
pituitary. The final day of the cycle is estrus, the fertile period. During estrus, levels of 
LH and GnRH are low, whereas estradiol and progesterone levels remain physiologically 
high. It is the unknown signal(s) that mediate this important feedback of peripheral 
gonadal hormones to the brain, signaling that the time is right for ovulation, and 
stimulating GnRH release on proestrus, which is the particular focus of the studies 
outlined in this dissertation.
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Luteinizing Hormone and Ovulation
LH is a 30,000 MW glycoprotein that is synthesized and secreted from 
gonadotropes in the anterior pituitary. In female rats and other mammals, LH and follicle 
stimulating hormone (FSH), another glycoprotein made in the anterior pituitary, are 
necessary for final follicular growth and maturation leading to ovulation. Both hormones 
consist of two polypeptide chains linked by hydrogen bonds and internal cross-linking 
disulfide bonds. LH and FSH are composed of identical 89- amino acid alpha chains, and 
a 115- amino acid beta chain unique to each hormone. Complex carbohydrate side chains 
are attached to specific locations on both the alpha and beta chains. The alpha and beta 
chains are synthesized separately and are combined before addition of the carbohydrate 
moeities.
FSH and LH bind to high affinity receptors in the ovaries that are glycoprotein 
encoded by homologous genes and are characterized by seven transmembrane-spanning 
domains. A large extracellular N-terminus region forms the specific binding site for each 
gonadotropin. The C-terminus is intracellular and mediates receptor down-regulation, and 
the generation of second-messenger signals. Both LH and FSH receptors demonstrate 
distinctive calcium signaling properties, and when bound by agonists activate adenylyl 
cyclase. The cAMP generated then triggers the activation of its protein kinase and 
subsequent phosphorylation of proteins necessary for steroidogenesis and ovulation.
During the follicular phase of the estrous cycle, FSH stimulates several follicles to 
accelerate maturation by binding to its receptors on the granulosa cells, leading to an
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increased enzymatic activity to aromatize androgens to estradiol. As estradiol levels 
increase and follicles develop, FSH levels drop and the developing follicles begin to 
synthesize increased numbers of LH receptors. On proestrus, positive feedback from 
estradiol causes a large surge of GnRH release, which then stimulates LH release. This 
LH induces the production o f prostaglandin F2-aIpha, progesterone and proteolytic 
enzymes at the follicular level. These ultimately cause follicular rupture and ovulation. 
Recent data indicate that increases in progesterone itself, or a similar adrenal steroid, may 
actually preceed the LH surge and contribute to its stimulation and timing. At any rate, 
following ovulation, the corpus luteum continues to make and secrete progesterone to 
prepare the uterus for implantation of a fertilized ovum. The high concentrations of 
estradiol and progesterone present just after ovulation then cause negative feedback upon 
GnRH, FSH and LH release. The resulting drop in LH secretion prevents further 
production of estradiol and progesterone. As the concentration of these gonadal steroids 
decrease, the degenerating uterine endometrial cells are attacked by leukocytes, preparing 
the reproductive system for its next cycle.
GnRH
GnRH, also known as luteinizing hormone-releasing hormone (LHRH), is a 
decapeptide hormone and neurotransmitter. GnRH neuron cell bodies originate in the 
MPO and the organum vasculosum of the lamina terminalis (OVLT) o f the rostral 
hypothalamus (RH). They are widely distributed and few in number (Carillo 1980). 
GnRH projections are sent from the MPO to the ME, where GnRH is secreted into the
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hypophysial portal blood, which carries the hormone to a second capillary bed in the 
sinusoids o f the anterior pituitary, where GnRH binds to specific seven-transmembrane, 
G-protein coupled receptors.
In addition to being located in the anterior pituitary, GnRH receptors are also 
found in various other areas of the brain. These include the ventromedial nucleus o f the 
hypothalamus (VMN), the lateral septal nucleus, the anterior cingulate cortex, and the 
subiculum (Jennes and Conn 1994). GnRH stimulation of these receptors is thought to 
mediate sex-related behaviors such as lordosis in the female rat. Thus, GnRH has central 
effects in addition to its role in stimulating LH and FSH release from the pituitary gland.
Activation of the GnRH receptor is coupled to the Gq/Gl 1 signal transduction 
system, which activates phospholipase C. This enzyme leads to the generation of several 
second messenger molecules. Among these, diacylglycerol (DAG) and inositol 1,4,5-tris- 
phosphate (EP3) are critically important. Inreased in DAG leads to activation of protein 
kinase C, which causes a series of intracellular changes, and EP3 causes increased release 
of calcium from intracellular pools (Diedricht 1999). GnRH receptor synthesis is subject 
to a positive feedback loop, whereby the levels of receptor-bound GnRH positively 
influence GnRH receptor synthesis (Stojijlkovic et al. 1994). Thus, one result of the 
signal transduction pathway for GnRH receptor stimulation is that transcription and/or 
translation o f GnRH receptor genes is increased upon binding.
GnRH synthesis and release in the female rat is linked both to increased 
intracellular calcium levels in GnRH neurons, and transcription of a number of important 
immediate early genes (IEG), especially Fos and Jun (Finn, Steiner, and Clifton 1998).
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This is important to note, as a number o f studies using EEGs as markers of cellular 
activity have identified areas in the medialbasal hypothalamus (MBH), other than the 
ME, which are important for the cyclic synthesis and release of GnRH in the female rat. 
Further, increased Fos induction is seen in GnRH neurons on the afternoon of proestrus 
in female rats (Hoffman, Smith and Verbalis 1993; Hoffman 1993), and GnRH genes are 
plausible targets for activation by Fos and Jun (Berriman 1992).
Control of GnRH Release
Pulsatile GnRH release is regulated, in part, by circulating gonadal steroid levels. 
At most times during the reproductive cycle estradiol and/or progesterone provide 
negative feedback to GnRH and LH release. However, GnRH release can be stimulated 
by progesterone administered to estradiol primed, ovariectomized (OVX) animals 
(Levine 1997). This effect can be blocked when progesterone receptors are antagonized 
(Chappel and Levine 2000), which indicates an important role for both gonadal steroid 
hormones in the generation of the proestrous GnRH surge. Interestingly, GnRH neurons 
do not express appreciable estradiol or progesterone receptor protein (Simonian and 
Herbison 1997), and thus are thought to indirectly sense changing levels of gonadal 
steroids. However, estradiol and progesterone receptors are present on a number of other 
neuronal phenotypes, many of which make connections with GnRH neurons. It is 
hypothesized that it is through these neurons that the brain detects peripheral estradiol 
and/or progesterone levels in order to regulate GnRH secretion.
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A number of central neurotransmitters have been shown to influence GnRH 
synthesis and release, and thus LH synthesis and release. These are summarized in Table 
1-1. Norepinephrine (NE), neuropeptide Y (NPY), glutamate, oxytocin (OT), and galanin 
all have been shown to stimulate GnRH release. NE seems to play a role in both the 
preovulatory, proestrous GnRH surge, and in regulating basal secretion throughout the 
estrous cycle (Legan and Callahan 1999). Both NPY and glutamate are involved in 
stimulating the proestrous surge at the level of the ME, where GnRH is released (Prevot 
et al. 1999). OT’s role is negligible on all days of the cycle other than proestrus. 
However, on the afternoon o f proestrus, OT has been shown to stimulate the preovulatory 
LH surge when given directly into the CNS (Johnston et al. 1992). Interference with 
endogenous OT via antibodies, OT receptor antagonism, conjugation of OT with the 
neurotoxin ricin, or OT antisense administration on the afternoon of proestrus blocks or 
attenuates the preovulatory GnRH and/or LH surge (Johnston et al. 1992; Johnston et al. 
1990; Cheesman et al. 1977; Samson et al. 1992). Galanin has also been implicated in the 
stimulation of GnRH release on proestrus. Galanin mRNA has been localized on GnRH 
neurons and is dramatically upregulated during proestrus and estrus (Finn et al. 1998). 
Further, upregulation of galanin gene expression has been linked to the GnRH and LH 
surges (Finn et al. 1998). The galanin gene may be a target for activation by Fos and Jun, 
the two IEGs associated with estradiol- induced GnRH release (Hrabosvky 1995). Thus, 
several neurotransmitters have been implicated in the stimulation o f GnRH release.
Agents inhibitory to GnRH secretion include beta-endorphin, y-aminobutyric acid 
(GABA), and corticotropin releasing factor (CRF). Beta-endorphin is involved in the 
tonic regulation of GnRH secretion, and administration of a beta-endorphin agonist
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attenuates the GnRH surge (Polkowska, J and Przekop, 1997). CRF, which is secreted in 
response to stress, is also a potent inhibitor of proestrus GnRH secretion (Polkowska and 
Przekop 1997). The fact that stress is one of the most common causes of female infertility 
relates directly to this phenomenon.
That so many neurotransmitter systems influence GnRH release makes sense from 
an evolutionary standpoint, as reproduction can continue despite the loss of one the 
controlling factors of GnRH release. For instance, both chronic blockade of alpha- 
adrenergic receptors, and lesions of noradrenergic neurons in the locus ceureleus abolish 
normal reproductive cycles in the rat. However, normal reproductive cycles return after a 
few weeks, and further manipulations of the noradrenergic system have little effect on re­
established pulsatile GnRH release. Thus, it appears that the loss of one neuronal system 
involved in control of cyclic GnRH release can be compensated for by the actions of 
others. This represents an important principle of redundancy, which enhances the 
likelihood of survival o f the species (Berriman, 1992).
Norepinephrine
NE has been implicated in the regulation of both tonic and pulsitile GnRH release 
(Legan and Callahan 1999; Gallo 1980). This catecholamine is made primarily in the 
locus ceuruleus of the caudal midbrain and upper pons o f  the brainstem. From there, Al 
and A2 NE projections are sent to targets throughout the brain, including several involved 
in reproductive behavior. These include the preoptic area (POA), MPO (Legan and
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Callahan 1999) and the PVN (Daftary, Boudaba, and Tasker 2000). NE neurons in the 
Al field have estradiol receptors (Simonian and Herbison 1997b), and NE turnover in the 
MPO as well as the ME parallels changes in circulating LH concentrations, such that NE 
secretion increases around the time o f the preovulatory LH surge (Crowley et al. 1978; 
Honma and Wutke 1980). Moreover, immunocytochemistry (ICC) and in situ 
hybridization studies reveal there are synaptic contacts between noradrenergic terminals 
and GnRH cells in the POA (Barraclough and Wise 1982; Kalra and Kalra 1983).
NE binds to several different receptor subtypes. In terms of NE’s effects on 
fertility and sexual behavior, alpha- adrenergic receptors have been most implicated. 
Antagonism of NE alpha- adrenergic receptors by administration of phenoxybenzamine 
blocks the LH surge (Weick 1978), as does blockade of NE synthesis (Legan and 
Callahan 1999) in female rats. In OVX female rats, intracereberbroventricular (ICV) 
administration of 5-amino-2,4-dihydroxy-methylphenylethylamine, a selective depletor 
of brain norepinephrine, reduces GnRH mRNA levels (Kang et al. 1998). In vitro 
administration of the catecholaminergic depletor, 6-hydroxydroxydopamine, to MBH 
explants reduced GnRH mRNA levels, and this reduction was reversed by treatment with 
NE (Kim et al. 1993), indicating a direct effect of NE on GnRH synthesis. N-(2- 
chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4), a highly selective NE neurotoxin, 
suppressed estradiol stimulated GnRH release in vitro, reduced levels of GnRH mRNA in 
the POA, and caused a reduction of GnRH-receptor mRNA in the pituitary (Kang et al. 
1998). In the OVX ewe, another animal frequently used in fertility studies, levels of 
statically expressed dopamine p-hydroxylase, the enzyme which converts dopamine to 
NE within synaptic vesicles, decreased in the MPO in estradiol-primed, OVX animals as
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visualized by ICC (Kotwica et al. 1996). This was thought to indicate an increase in 
conversion of dopamine to NE during the late follicular stage of the ewe, which parallels 
proestrus in rats. In the rabbit, LH surges are induced following coitus, and this induction 
has been linked to increased release of NE in the MBH (Kaynard et al. 1990). Thus, data 
from a variety of species indicate an important role for NE in the GnRH and LH surges.
Oxytocin
Another putative stimulator of GnRH is OT. OT is a nanopeptide hormone and 
neurotransmitter, and is very similar to arginine vasopressin (AVP) in structure but not 
function. OT cell bodies are concentrated in the anterior portion of the paraventricular 
(PVN) and in the supraoptic (SON) nuclei of the hypothalmus (Peterson and Guillemin 
1974). The main projection of OT neurons is to the posterior pituitary, where it is 
secreted as a hormone in response to suckling in nursing mammals, at the onset of 
parturition, and in response to stress. Projections are also sent to the ME, where it has 
been postulated that OT stimulates GnRH secretion (Rettori et al. 1974), and where OT is 
released into the hypophysial portal blood to influence anterior pituitary activity. Other 
OT projections are sent to areas in the hypothalamus containing GnRH cell bodies 
including the MPO, the OVLT, and the VMN. Sub-populations of OT neurons display 
nuclear estradiol receptors, and these may be involved in OT’s role in stimulating GnRH 
(Dufau and Catt, 1978).
The OT receptor is very similar to that for vasopressin. It belongs to the G- 
protein coupled, seven transmembrane receptor family. In the periphery, OT receptors are
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found in the uterus, mammary gland, and pituitary lactotropes and corticotropes. In the 
brain, the receptor is found in a variety o f nuclei involved in both the GnRH surge and 
sexual behavior. These include the VMN, the MPO, the OVLT, and the SON (Ludwig 
1995). Activation of the OT receptor is coupled to the inositol phosphate (EP3)/ calcium 
second messenger system. OT binding thus causes an increase in IP3, DAG, and 
ultimately, free intracellular calcium. It has been postulated that there are subtypes of OT 
receptors specific for 4-90T, a potent metabolized version of OT in the brain, but these 
have not been characterized (Lopes-da Silva, Adan and Burbach 1993).
OT and OT receptor mRNA both are influenced by circulating estradiol levels 
(Bale et al. 1995; Quinones-Jehab et al. 1997). In OVX animals, estradiol- priming 
increases OT mRNA levels in the rat hypothalamus, and this phenomenon is greatly 
enhanced when progesterone is initially administered with estradiol, then subsequently is 
slowly withdrawn (Bale at al. 1990). Message expression of the OT receptor varies 
throught the estrous cycle, with a 15-fold increase in that expression being seen in the 
VMN from the morning to the afternoon of proestrus (Bale, Dorsa, Johnston 1995). This 
supports a role for changing estradiol and progesterone levels in the regulation of OT 
synthesis. Further, the rat OT gene contains a consensus sequence for an estradiol 
response element (Quinones-Jelab et al. 1997).
While central administration of OT has previously been shown to stimulate 
elevated plasma LH on proestrus (when estradiol levels are high), but not on metestrus or 
diestrus (Johnston et al. 1992), whether OT directly stimulates GnRH on proestrus in the 
female rat is not known. Presumably it does, since the effect of OT on LH stimulation is a 
centrally mediated phenomenon and can be blocked by central administration of both OT
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antisera and a GnRH antagonist (Johnston et al. 1990). However, this has yet to be 
proven. Another unknown is the site in the brain where OT is working to stimulate LH 
release. These represent two of the primary questions examined in the research for this 
dissertation.
Nitric Oxide
Nitric oxide (NO) has been shown to play a role in cyclic GnRH release in the 
female rat both at the level o f the ME and in the MBH (Herbison et al. 1996). NO is 
synthesized by a number of related NO-synthase (NOS) molecules in neurons, 
endothelial cells, platelets, and neutrophils in response to homeostatic stimuli (Mondcada 
1992). NOS is a complex enzyme which acts on molecular oxygen and arginine to 
produce NO and citrulline. This process involves five essential cofactors and two divalent 
cations (calcium and heme iron). NO interacts with the heme prosthetic group of 
guanylate cyclase, activating the enzyme and leading to increased cylcic GMP levels. 
Evidence has been presented for a role of constituitively expressed neuronal NOS 
(nNOS) and endothelial NOS (cNOS), in the stimulation of LH and GnRH release on the 
afternoon of proestrus in female mammals (Lamar et al. 1999; Lozach et al. 1998).
Several lines of evidence also provide evidence that NO plays a role in the 
stimulation of GnRH during proestrus. NO feeding via the nitrogen donor, sodium 
nitroprusside, enhances proestrous GnRH secretion in vitro (Bonavera et al. 1993; Mani 
et al. 1994). NO synthesis in the MBH, as measured by the by-product of NOS synthesis 
o f NO, citrulline, is highest on the afternoon of proestrus (Canteros et al. 1996). In the
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ME, estradiol has been shown to stimulate NO release from endothelial cells in ME 
explants, and this stimulation of NO was accompanied by increased release of GnRH 
from GnRH nerve terminals. These effects were blocked by administration of the 
estradiol antagonist, tamoxifen (Prevot et al. 1999). Further, it has been shown that when 
NO- stimulated guanylyl cylclase activation was inhibited using 1H- 
(l,2,4)oxadiazolo(4,3a)quinoxalin-l-one (ODQ), a potent and selective inhibitor of NO 
sensitive guanylyl cyclase, estradiol stimulated GnRH release from the ME is eliminated 
(Prevot et al. 1999). nNOS mRNA has been demonstrated to be present in the 
immortalized GnRH synthesizing cell line, GT1, and these cells also produce the by­
product o f NO synthesis, citrulline.
No evidence for nNOS in GnRH cells has been demonstrated 
immunocytochemically in vivo. However, Herbison et al. (1996) reported a distinct band 
of nNOS containing- neurons in the MPO abutting GnRH cell bodies. Neurons 
containing neural NO synthase (nNOS) are also found in various locations in the 
hypothalamus that have been linked to reproduction, especially the PVN and SON 
(Amico et al. 2000). These neurons have axons projecting to the ME and extending into 
the neural lobe, where the highest concentration o f NOS immunoreactivity is found in the 
rat brain (McCann 1998). Further, NOS- like activity has been demonstrated in the MPO 
and VMN, and this, in conjunction with the previously discussed biochemical 
information, indicates that NO could be involved in both the generation of the GnRH 
pulse, and in GnRH mediated reproductive behaviors.
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Interaction Between the OT. NE. and NO Systems on Reproductive Behaviors
Interaction between the OT, NE, and NO systems on GnRH release has been 
demonstrated in several different ways. Anatomically, two or more o f these systems have 
been shown to overlap in the VMN, MPO, SON, PVN, and ME regions via histochemical 
techniques (Mcann et al. 1998; Rettori et al. 1997; Daftary, Boubadaba, and Tasker 
2000). As mentioned earlier, Fos induction in the hypothalamus has been shown via ICC 
to be a precursor o f GnRH synthesis and release in female rats on the afternoon of 
proestrus. Both NE and OT have been linked to induction o f Fos in the SON and the PVN 
(Conde et al. 1996; Flanagan et al. 1993), and it has been shown that NE stimulates OT 
release as well as Fos induction in the PVN (Bealer and Crowely 1999). Further, NOS- 
containing neurons in the SON have been shown to synthesize OT as well as express Fos 
(Hatakeyama et al. 1996). Thus, there is strong anatomical proof o f overlap between 
these three neurotransmitter systems in hypothalamic areas known to be involved in the 
generation of the GnRH surge.
In addition to anatomical evidence for interaction between NE, OT, and/or NO, 
links between the three have been made via biochemical investigation. As previously 
mentioned, the NE, OT and NO neurotransmitter systems have been shown to be 
sensitive to changing estradiol levels. Other evidence indicates that these responses to 
estradiol might be interlinked. Vincent and Etgen (1993) demonstrated that steroid 
priming via estradiol promotes OT- induced NE release in the VMN in female rats in 
vivo. OT has been shown to influence NO synthesis in the MBH, and NE influences NO
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at both the level of the ME and the MBH in males (Rettori et al. 1997). Taken together, 
this evidence indicates significant interaction and interplay between these three systems 
in the generation o f GnRH release, and GnRH mediated reproductive behaviors. These 
interactions are the major focus of the research presented here.
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Figure 1-1. Schematic of events involved in ovulation. Estrogen and progesterone levels 
are sensed by the hypothalamus, resulting in the secretion of gonadotropin-releasing 
hormone (GnRH) into the portal blood at the median eminence. GnRH travels from there 
to the pituitary, where it stimulates its receptors. This in turn causes the release of 
luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary, 
which stimulate receptors in the ovaries, ultimately causing follicular rupture and 
ovulation.
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Figure 1-2. (opposite page). Approximate secretion levels o f gonadortropin- 
releasing hormone (GnRH), luteinizing hormone (LH), estradiol, and 
progesterone throughout the rat estrous cycle. The vertical dotted line 
indicates the time of ovulation.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18
' ^ : v -
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Table 1-1 Neurotransmitters Involved in the Central Control of GnRH Release
Neurotransmitter Action on GnRH/LH Site(s) of Action Origin
Norepinephrine Stimulatory/Inhibitory ME, MBH Brainstem
Glutamate Stimulatory ME, Pituitary (?) MBH, many other 
brain areas
Oxytocin Stimulatory on proestrus BH(?), ME(?), 
Pitiuitary (?)
PVN, SON
Nitric Oxide Stimulatory on proestrus ME, MBH, 
Pituitary
nNOS, iNOS, 
cNOS
Galanin Stimulatory ME, MBH
B-endorphin Inhibitory (Tonic) ME, MBH
VMN
GAJBA Inhibitory ME, MBH
VMN (terminals)
CRF Inhibitory ME, MPO, OVLT
Hypothalamus
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Specific Aims
The specific aims of this research are to:
1. Investigate the role of OT in the generation of the preovulatory GnRH suge by 
determining whether OT is able to stimulate GnRH release from ME or BH 
explants harvested on the afternoon of proestrus from normally cycling female 
rats.
2. Develop a dose-response curve for OT- induced stimulation of GnRH from 
proestrous BH explants.
3. Examine the mechanisms of OT- induced stimulation of GnRH release by testing 
whether OT and alpha- adrenergic receptor antagonists, or NOS inhibition, can 
influence OT- induced stimulation of GnRH release from proestrous BH explants.
4. Investigate the role of NE in the generation of the preovulatory GnRH surge by 
determining if NE can stimulate GnRH release from BH explants harvested on the 
afternoon of proestrus from normally cycling female rats, and develop a dose- 
response curve for NE- induced stimulation of GnRH release from proestrous BH 
explants.
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5. Examine the mechanisms of NE- induced stimulation of GnRH release by testing 
whether OT and alpha- adrenergic receptor antagonists can influence NE- induced 
stimulation o f GnRH release from proestrous BH explants.
6. Investigate whether there is interaction between NE and OT on stimulating GnRH 
release by examining the ability of sub-maximal doses o f OT or NE alone, or in 
combination, to stimulate GnRH release from proestrous BH explants.
7. Examine the mechanisms of combined NE/OT- induced stimulation of GnRH 
release by testing whether OT and alpha- adrenergic receptor antagonists, or NOS 
inhibition, can influence NE/OT- induced stimulation of GnRH release from 
proestrous BH explants.
8. Investigate the role of NO in NE/OT- induced stimulation of proestrous GnRH by 
determining whether NE and/or OT can stimulate NO synthesis in proestrous BH 
explants, and test the ability of OT receptor antagonism on NE/OT- induced NO 
stimulation.
9. Examine the ability of NE and/or OT to stimulate GnRH and NO from BH 
explants harvested on the afternoons of estrus and diestrus versus proestrus.
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Chapter 2: Materials and Methods 
Animals
Young adult female Sprague-Dawley rats (Simonson Labs, Gilroy, CA) weighing 
200-250 grams were housed four to a cage, with food and water ad libitum, in an 
AAALAC accredited vivarium. Room temperature was kept at 23 + 1°C, with lights on 
from 0700hr to 1900hr. Only animals displaying two consecutive, normal four to five day 
estrous cycles were used in these experiments.
After at least one week of acclimatization to new housing and lighting conditions, 
rats were handled daily in order to accustom them to being manipulated by the 
researcher. Following several days of handling, tails were marked for individual 
identification. Vaginal cytology was then examined daily using a vaginal lavage method: 
A) the animal was picked up and placed feet first on the tester’s forearm, B) the tail was 
raised and a glass eyedropper with a small amount of water (approximately 0.5ml) was 
inserted into the vagina, C), after lavage, the eyedropper fluid was smeared onto 
numbered, clear glass slides and left to air dry, D) slides were then immersed for five 
seconds in 100% methanol for fixation, and after drying, in 0.05% methylene blue in 
ddH20 for approximately two minutes, then, E) slides were washed three times in fresh 
cold water, and set to air dry. Slides were examined using a light microscope at 10X 
magnification in order to determine the changes in vaginal cytology, and stage of the 
cycle.
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Figure 2-1 demonstrates how the estrous cycle is readily discemable via light 
microscopy examination o f vaginal cytology. The first day o f the cycle is called diestrus 
one, or more commonly, metestrus. The influence of estradiol or progesterone is minimal 
on metestrus, and vaginal cytology reveals a sea of leukocytes descending upon, 
surrounding and destroying the comified cells of estrus to begin another cycle. The 
second day of the cycle is called diestrus two, or simply diestrus. On diestrus, when 
estradiol exerts a limited influence, vaginal cytology consists of a small number of any or 
all cell types, including leukocytes, epithelial and comified cells. On the third day of the 
estrous cycle, proestrus, high levels o f estradiol and increasing levels o f progesterone 
stimulate induction of the preovulatory GnRH surge. Vaginal cytology on proestrus 
reveals an abundance of small, round, nucleated epithelial cells, which often clump 
together or align in strands. On the fertile day of the cycle, estrus, vaginal cytology, under 
the strong influence of progesterone and estradiol, reveals large, enucleated comified 
cells, which tend to clump together. These cells are rich in nutrients, and should an egg 
be fertilized, provide an excellent environment for implantation and nutrition.
Tissue Preparation
At 1500hr, animals determined to be at the proper stage of the estrous cycle were 
decapitated. Brains were quickly removed and the basal hypothalamus (BH) or ME was 
rapidly dissected using a dissecting microscope and fine iris scissors. The tissues were 
immediately placed in 0.5 ml preincubation Krebs-Ringer Bicarbonate buffer medium 
(pH 7.4) supplemented with 1.8 mg glucose, 10 ug/ml ascorbic acid, 1.3 mM Ca2+, and 1
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mg/ml aprotinin (KRBG) for 30 minutes. All incubations were carried out in a metabolic 
shaker (30 cycles/min, supplied with 95% 02/5% CO2 at 37°C). The 30 minute 
preincubation period was determined empirically as the minimum time necessary for 
stable, basal GnRH secretion to be restored following harvesting of tissue. The 
preincubation media was discarded and replaced following 30 minute increments with 0.5 
ml KRBG, alone, to determine basal (control) GnRH secretion levels, or KRBG 
containing OT (10’9M to 10'1SM), NE (10'6M to 10'IOM), OT (10'IlM) and NE (10'8M) 
combined, the NO synthesis inhibitor, N-nitro-L-arginine methyl ester (LNAME, 10'6M), 
the kainite receptor antagonist, NBQX (10'6M), the alpha-1 adrenergic receptor 
antagonist, prazosin (PRZ, 10'6M), the alpha-2 receptor adrenergic antagonist, yohimbine 
(YO, 10'6M), the OT receptor antagonist, [d(CH2)s, Tyr (Me)2, ORN8] vasotocin, (OTA, 
10'6M), or combinations thereof. Following each 30 minute test incubation, the medium 
was removed and stored at -80°C until assayed for GnRH and/or nitrate/nitrite content.
Lowry Protein Assay
The amount of protein for each tissue sample was determined using a modified 
Lowry protein assay. Following overnight incubation in 0.5 ml IN NAOH, tissue 
samples were vortexed until the solutions were homogenous. Tubes were labeled Blank, 
A-D in duplicate (to construct a standard protein curve), and 1-N in duplicate for the 
number of samples. For determination of a standard protein curve, standard stock 
solutions were prepared from a stock solution of one gram bovine serum albumin 
(fraction V) (BSA)/ml H2O. The standard curve was constructed by adding 50 ul of
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distilled H2O (blanks) and 50 ul o f distilled H2O containing 0 ug — 50 ug protean to the 
appropriate tubes, followed by 50 ul IN NAOH. The proper dilution aliquot o f  sample 
was then added to the appropriately labeled tubes, followed by distilled H2O to b ring  total 
volume up to 100 uL. Reagent ‘A’ was then prepared by adding Sodium Carbonate: 
Cupric Sulfate: KNa Tartrate in that order in the following proportion — 100: 1 : 1 .  One 
milliliter of reagent A was then added to each assay tube, with each tube vortexed 
following addition. Ten minutes following the addition of reagent ‘A’ to each tube, 100 
ul folin reagent (phenol: distilled H2O at 1:1) was added, and each tube was wortexed 
following each addition. Thirty minutes following the first addition of folin reagent, 
standards and samples were read at a 660 nm wavelength using a Stafford III 
spectrophotometer (Gilford Instruments, Oberlin, OH). A standard curve was manually 
constructed by taking the average number of fluorescent units o f each pair of standard, 
subtracting out the average blank, then dividing the result with the known anmount of 
protein (in micrograms) for each pair. The average of these numbers was divided into the 
counts for each dilution of unknown sample (minus blank), and the total micrograms of 
protein determined from the dilution factor.
Radioimmunoassay
Radioimmunoassays (RIA) were performed using standard double-antibody 
GnRH RIA kits (Peninsula Laboratories, Inc., San Carlos, CA). The assay is based, on the 
competition between l25I-GnRH and unlabeled peptide (either standard or unknown) 
binding to a specific primary antibody added at a dilution of 1:20,000. An increase in the
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concentration of standard or unknown GnRH peptide reduces the amount o f 125I-GnRH 
able to bind to the antibody. By measuring the amount of labeled GnRH bound as a 
percentage of total binding possible for each standard reaction mixture, a standard curve 
was constructed. The amount of GnRH in unknown samples was then determined using 
the standard curve.
Following reconstitution o f RIA buffer, standard GnRH peptide, and rabbit-anti 
GnRH, a standard dilution series was created (Table 2-1).
Table 2-1: GnRH Peptide Dilution Series
Tube Sample RIA Buffer GnRH GnRH/100ul
Stock powder 1 ml 12.8ug/ml -
O 40ul stock 960ul 5.12ng/ml 512pg/100ul
A 10ul O 990ul 2.56ng/ml 256pg/100ul
B 500ul A 500ul 1.28ng/ml 128pg/100ul
C 500ul B 500ul 0.64ng/ml 64pg/100ul
D 500ul C 500ul 0.32ng/ml 32pg/100ul
E 500ulD 500ul 0.16ng/ml 16pg/100ul
F 500ul E 500ul 0.8ng/ml 8pg/100ul
G 500ul F 500ul 0.4ng/ml 4pg/100ul
H 500ul G 500ul 0.2ng/ml 2pg/100ul
1 500ul I 500ul 0.1ng/ml 1pg/100ul
Tubes were then labeled in triplicate TA (total activity), NSB (non-specific 
binding), and in quintuplicate TB (total binding), and appropriately for the standard 
curve. Two hundred microliters o f RIA buffer was added to the TA and NSB tubes, and
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100 ul to TB tubes. One hundred microliters o f standard H through A was pipetted in 
triplicate into tubes #12-44, starting with the lowest concentration (tube H) and 
continuing with higher concentrations through tube A. Ten microliters, 5 ul, or lul of 
unknown sample was then added to tubes #45 and up, and the total amount in each tube 
was brought up to 100 ul by adding RIA buffer. Primary antibody was then added to all 
but the TA and NSB tubes, and each tube was vortexed. All tubes were then covered with 
aluminum foil and allowed to incubate overnight (16-24hrs) at 4°C.
On the second day of the assay, l25I-GnRH was reconstituted with 1 ml of RIA 
buffer, and mixed thoroughly. The tracer was diluted to a concentration of approximately 
25,00 cpm/100 uL. One hundred microliters o f tracer was added to each test tube in the 
assay, they were vortexed, covered and allowed to incubate overnight (16-24hrs) at 4°C.
On the third day of the assay, a secondary Goat Anti-Rabbit IgG serum was 
reconstituted to a concentration of 1:22, and 100 ul was added to every test tube. Normal 
Rabbit Serum was then reconstituted to a concentration of 3% and 100 ul added to each 
tube. All tubes were vortexed and allowed to incubate at room temperature for 90 
minutes. Five hundred microliters of RIA buffer was then added to each tube, and all but 
the TA tubes were vortexed, then centrifuged in a Beckman Model J-6B centrifuge for 35 
minutes at 2,500 RPM. Supernatant from the centrifuged tubes was carefully aspirated, 
leaving a pellet. Pellets containing bound ligand-antibody from all tubes were then 
counted using a gamma counter (Apex Automatic Gamma Counter, ICN Micromedia 
Systems, Model 28026). Software by Isodata was used in order to quantitate a standard 
curve, and calculate the number of picograms GnRH per tube for unknown samples. 
Final data were reported as nanograms GnRH/mg protein/ml/hour.
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Measurement of Nitric Oxide; The Griess Reaction
NO was measured using nitrate/nitrite assay kits (Cayman Chemical, Cat # 
780001). NO is produced in trace amounts in neurons and other cells, and is rapidly 
scavenged to nitrates and nitrites (Tl/2 = 4 seconds). For this to occur, NO undergoes a 
series of reactions with several molecules present in biological fluids, including:
NO + 0 2- -> 0 N 0 2. + F r ^  NOj. + ET 
2NO + 0 2 -> N20 4 + H20  -> N 0 2. + N 03 
NO + N 0 2 -> N20 3 + H20  -> 2N 02.
The final in vivo products of NO are nitrite (N 02.) and nitrate (N 03.). The relative 
proportion of nitrite/nitrate is variable and cannot be predicted with certainty. Thus, the
best index for total NO production is the sum of both, and that is what was measured in
these assays. Once conversion of nitrate to nitrite was completed, Griess Reagents are 
added. These convert nitrite into a deep purple azo compound. Photometric measurement 
of the absorbance due to this azo chromophore accurately determines nitrite 
concentration when compared to standard curves.
The assay was run as follows: the assay buffer was diluted to 100 ml with HPLC- 
grade water. This buffer was used to reconstitute nitrate reductase, enzyme cofactors, and
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nitrate standard. One-tenth of the reconstituted nitrate standard was then added to 0.9 ml 
assay buffer and vortexed. Using this diluted standard, a standard curve was made in a 96 
well plate as depicted in Table 2-2 (with the addition o f two blank wells filled with 200 ul 
o f buffer only):
Table 2-2. Preparation of Standard Nitrate/Nitrite Curve
Well Nitrate Standard Assay 
Buffer
Nitral
A1 Oul 80ul OuM
B1 3ul 77ul 3uM
C1 6ul 74ul 6uM
D1 9ul 71 ul 9uM
E1 12ul 68ul 12uM
F1 15ul 65ul 15uM
G1 18ul 62ul 18uM
H1 21 ul 59ul 21 uM
11 24ul 56ul 24uM
Eighty microliters of unknown sample was then added to the necessary number of wells. 
Ten microliters of enzyme cofactor mixture was then added to each well, followed by 10 
microliters of nitrate reductase (except blank wells). The plate was then covered with a 
plate cover, and incubated at room temperature for 2 hours. After this incubation time, 50 
ul o f Griess reagent 1 was added to the standards and unknowns, followed by 50 ul of
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Griess reagent 2. Photometric measurement of absorbance was then made at 540 nM 
using a microplate reader (Molecular Devices, Thermomax Microplate Reader) running 
Softmax Pro vl.2 software. A standard curve was generated using the software, and the 
micromolar content of nitrite in each sample well was determined.
Statistics
Statistics for these experiments were performed using either Microsoft Excel (raw 
data entry, mean), or Prism Graph Pad software. Comparisons between pairs of 
individual groups were made using the student’s t-test, and comparisons between 3 or 
more groups by one-way analysis of variance plus the Newman-Keuls post-test. The level 
o f probability used as the minimum criterion of significance was p < 0.05 for all 
experiments. Because basal levels of nitrate/nitrite release varied between animals, but 
relative patterns of reactivity to the treatments did not, in the case o f the nitrate/nitrite 
assays, each animal was it’s own control. Basal secretion was considered as 100%, and 
nitrate/nitrite levels were graphically expressed as percent of basal control. Levels of 
significance for the NO studies were determined using raw data.
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Figure 2-1. Vaginal cytology on metestrus, the first day of the estrous cycle
Vaginal cytology on metestrus reveals a sea of leukocytes, which devour the 
comified cells of estrus as the animal begins another estrous cycle.
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Figure 2-2. Vaginal cytology on diestrus, the second day of the estrous 
cycle
Vaginal cytology on diestrus reveals a small number o f cells, o f mixed type. 
Cells from the previous estrous cycle are nearly gone, and a new uterine 
lining is forming.
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Figure 2-3. Vaginal cytology on proestrus, the third day o f the estrous cycle
Vaginal cytology on proestrus, when the GnRH surge occurs, reveals small, 
round, nucleated epithelial cells which are often clumped together in strands.
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Figure 2-4. Vaginal cytology on the final day of the cycle, estrus
Vaginal cytology on estrus reveals large, comified cells lacking nuclei. 
These provide nutrition for any ovum that might have been fertilized and 
implanted.
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Chapter 3: Results
Oxytocin Stimulates GnRH Release From the Proestrous BH But Not ME
Whether or not OT stimulates GnRH release from hypothalamic explants in order 
to cause its stimulation o f proestrous LH in vivo is unknown. To address this question, 
the ability of OT to stimulate GnRH release from proestrous ME explants, where GnRH 
nerve terminals are located and GnRH is released into portal capillaries was tested. Also 
tested was the ability of OT to stimulate GnRH release from proestrous BH explants, 
which included the ME as well as areas of the rostral hypothalamus containing GnRH 
cell bodies.
As illustrated in Figure 3-1, OT (10 ' l3M and 10 ~IlM) stimulated GnRH release 
from BH explants harvested on the afternoon of proestrus from normally cycling female 
rats. However, OT in the same concentrations failed to stimulate GnRH release from ME 
explants on proestrus. Since OT did not stimulate GnRH release from isolated ME 
fragments, a dose-response curve for OT- (10 ' I5M to 10 '9M) induced stimulation of 
GnRH from intact proestrous BH explants was constructed (Figure 3-2). The dose- 
response curve showed that OT- induced GnRH release from the BH occured at 
concentrations as low as 10'13 M, and and increased in a dose-dependent manner from 10 
-11M to 10 "9M.
In summary, the data demonstrate that the connectivity found in the intact BH is 
necessary for OT to stimulate GnRH release in a dose-dependant manner.
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Figure 3-1. OT- induced stimulation of GnRH from the ME versus the BH
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In vitro release of GnRH from either median eminence (ME) or basal 
hypothalamus (BH) explants obtained a t  1500hrs from normally cycling, 
proestrous female Sprague-Dawley rats. GnRH release is in response to 
buffer alone (control), or buffer containing oxytocin (OT, 10'UM or 10~I3M). 
Column heights represent mean GnRH (ng/mg protein/ml/hr) released, and 
vertical lines above columns denote tihe S.E.M. N=8 animals for all 
treatments. *, significantly different from basal control values (P<0.01).
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Figure 3-2. Dose-response curve for OT- induced stimulation of GnRH 
release from proestrous BH
Control (10'1SM) (10'13M) (10'11M) (1(rtU)
OT (M olar C o n cen tra tio n )
In vitro release of GnRH from basal hypothalamus (BH) explants obtained 
at 1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH secretion is in response to buffer alone (control), or buffer with 
oxytocin (OT, 10‘9M to 10‘I5M). Column heights represent mean GnRH 
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the 
S.E.M. N=8 animals for all treatments. *, significantly different from basal 
control values (P<0.01).
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OT- Stimulation of Proestrous GnRH release: Mechanism of action
In order to examine the mechanisms by which OT induces stimulation o f GnRH 
release from proestrous BH, the ability of antagonists of neurotransmitters/receptors 
thought to be involved in the generation of the preovulatory GnRH surge were tested. 
The antagonists used included: 1) the OT receptor antagonist, [d(CH2)s, Tyr (Me)2, 
ORN8] vasotocin (OTA); 2) the NO synthesis inhibitor, LNAME; 3) the alpha-L 
adrenergic receptor antagonist, prazosin; 4) the alpha-2 adrenergic receptor antagonist, 
yohimbine; and 5) the glutamatergic kainate receptor antagonist, NBQX.
As depicted in Figures 3-3 thru 3-7, OT’s ability to stimulate GnRH release from 
proestrous BH explants was blocked by both OT receptor antagonism (P<0.01) and by 
inhibition of NO synthesis (P<0.01). These results indicate that OT stimulates GnRH 
secretion from proestrous BH explants via an OT receptor mediated mechanism which 
works, at least in part, by the stimulation of NO. Receptor antagonists for alpha- 1 and 
alpha-2 adrenergic receptors did not attenuate OT’s ability to stimulate GnRH release in 
vitro from proestrous BH explants, nor did the glutamatergic kainate receptor antagonist 
NBQX. These results indicate that alpha-1 and alpha-2 adrenergic receptors do not 
mediate OT’s stimulation o f GnRH from proestrous BH explants. This would appear to 
rule out direct OT- induced stimulation o f NE as a cause of OT’s effects on GnRH 
release. Finally, glutamatergic kainate receptor antagonism failed to attenuate OT’s 
stimulation of GnRH release from BH tissues on proestrus. The data support the theory 
that OT does not require activation of alpha- adrenergic, nor kainate receptors to 
stimulate GnRH release. It does not, however, diminish the possibility that these systems
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may influence OT neurons, or work together or independently in order to cause the 
normal preovulatory surge of GnRH and LH.
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Figure 3-3. Effect o f kainate receptor antagonism on OT- induced GnRH
release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
oxytocin (OT, 10~llM) and/or the kainate receptor antagonist NBQX (10* 
6M). Column heights represent mean GnRH (ng/mg protein/ml/hr) released, 
and vertical lines above columns denote the S.E.M. N=8 animals for all 
treatments. *, significantly different from basal control values (P<0.01).
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Figure 3-4. Effect of alpha-1 adrenergic antagonism on OT- induced GnRH
release from proestrous BH
1 0 .0-1
C o n tro l
Treatm ent
In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
oxytocin (OT, 10'11M), and/or the alpha-1 adrenergic receptor antagonist 
prazosin, (PRZ, 10"6M). Column heights represent mean GnRH (ng/mg 
protein/ml/hr) released, and vertical lines above columns denote the S.E.M. 
N=8 animals for all treatments. *, significantly different from basal control 
values (PO.OOl).
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Figure 3-5. Effect of alpha-2 adrenergic antagonism on OT- induced GnRH
from proestrous BH
C o n t r o l OT/YO
T r e a t m e n t
In vitro release o f GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
oxytocin (OT, 10'lIM), an/or the alpha-2 adrenergic receptor antagonist 
yohimbine (YO, 10'6M). Column heights represent mean GnRH (ng/mg 
protein/ml/hr) released, and vertical lines above columns denote the S.E.M. 
N=8-9 animals for all treatments. *, significantly different from basal control 
values (P<0.001).
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Figure 3-6. Effect o f NOS inhibition on OT- induced GnRH release from
proestrous BH
10.0-1
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LNAME
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
oxytocin (OT, 10'lIM), and/or the nitric oxide synthesis inhibitor LNAME, 
(10'lIM). Column heights represent mean GnRH (ng/mg protein/ml/hr) 
released, and vertical lines above columns denote the S.E.M. N=8 animals 
for all treatments, *, significantly different from basal control values 
(PO.OOl).
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Figure 3-7. Effect of OT receptor antagonism on OT- induced GnRH 
release from proestrous BH
C o n tro l OT/OTA OTA
Treatment
In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
oxytocin (OT, 10*llM), and/or an oxytocin receptor antagonist (OTA, 10' 
6M). Column heights represent mean GnRH (ng/mg protein/ml/hr) released, 
and vertical lines above columns denote the S.E.M. N=8 animals for all 
treatments. *, significantly different from basal control values (P<0.01).
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Norepinephrine Stimulates GnRH Release On The Afternoon O f Proestrus
NE has previously been implicated in the control o f proestrous GnRH release. In 
order to further examine its role in stimulating GnRH release, the following studies were 
performed to 1) determine whether NE stimulates GnRH release from proestrous BH 
explants in vitro, 2) examine the dose-response relationship for NE stimulation of GnRH 
from proestrous BH explants, 3) determine whether NE stimulates GnRH from BH 
explants via alpha-1 or alpha-2 adrenergic receptors, and 4) determine the effect of OT 
receptor antagonism on NE- induced stimulation of GnRH from proestrous BH explants.
As depicted in Figure 3-8, NE stimulated GnRH release from proestrous BH 
explants in vitro. The effect of NE on GnRH did not dramatically increase as the dose 
rose from 10'8M to 10‘6M, indicating the system was near saturation. The ability of NE to 
stimulate GnRH release was blocked by the alpha-1 adrenergic receptor antagonist, 
prazosin (Figure 3-9, PO.OOl), but not the alpha-2 adrenergic receptor antagonist, 
yohimbine, (Figure 3-10). Administration of an OT- receptor antagonist attenuated the 
NE- induced release of GnRH from proestrous BH explants such that NE- induced 
stimulation of GnRH release was no longer significant in the presence of an OTA (Figure 
3-11).
These results confirm that NE stimulates the release o f GnRH from proestrous 
BH. That this effect was blocked by alpha-1, but not alpha-2 adrenergic receptor 
antagonism indicates NE is working through alpha-1 adrenergic receptors to stimulate 
GnRH secretion from proestrous BH explants. That OT- receptor antagonism also the 
inhibited NE- induced GnRH stimulation indicates that NE may, in part, be working
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through activation of the OT neurotransmitter system to stimulate GnRH release from 
proestrous BH explants.
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Figure 3-8. Dose- response curve for NE- stimulation o f GnRH release from 
proestrous BH
C on tro l (10 M) (10'8M) (1 0 "6!̂ !)
NE (Molar Concentration)
In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH secretion is in response to buffer alone (control), or buffer with 
norepinephrine (NE, 10'6M to 10‘loM). Column heights represent mean 
GnRH (ng/mg protein/ml/hr) released, and vertical lines above columns 
denote the S.E.M. N=8-10 animals for each treatment. *, significantly 
different from basal control values (PO.Ol).
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Figure 3-9. Effect o f alpha-1 adrenergic antagonism on NE- induced GnRH
release from proestrous BH
C o n t r o l NE/PRZ PRZ
Treatment
In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10‘8M), and/or the alpha-1 adrenergic receptor 
antagonist prazosin, (PRZ, 10'6M). Column heights represent mean GnRH 
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the 
S.E.M. N=8 animals for all treatments. *, significantly different from basal 
control values (P<0.001).
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Figure 3-10. Effect of alpha-2 adrenergic antagonism on NE- induced
GnRH release from proestrous BH
NE/YO
T r e a t m e n t
In vitro release of GnRH from basal hypothalamus (BE!) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10'8M), and/or the alpha-2 adrenergic receptor 
antagonist yohimbine (YO, 10'6M). Column heights represent mean GnRH 
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the 
S.E.M. N=9 animals for all treatments, *, significantly different from basal 
control values (P<0.01).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
50
Figure 3-11. Effect o f OT- receptor antagonism on NE- induced GnRH
release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10'8M), and/or an OT receptor antagonist (OTA 10'8M). 
Column heights represent mean GnRH (ng/mg protein/ml/hr) released, and 
vertical lines above columns denote the S.E.M. N=5 animals for all 
treatments, *, significantly different from basal control values (P<0.05).
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Interactions Between NE and OT in Stimulating GnRH Release In Vitro
Recent literature suggests that there is an interaction between NE and OT on the 
stimulation of GnRH release from male BH explants (Rettori et al. 1997). In order to test 
whether such an interaction occurs in a female model, the ability of combined OT/NE to 
stimulate GnRH release from proestrous BH explants was tested. Also examined was the 
ability of several pharmacological agents to block the combined NE/OT stimulation of 
GnRH from proestrous BH explants. These agents were the alpha-1 adrenergic 
antagonist, prazosin; the alpha-2 adrenergic antagonist, yohimbine; the NO synthesis 
inhibitor, LNAME; and the OT receptor antagonist [d(CH2)s, Tyr (Me)2, ORN8] 
vasotocin (OTA).
As depicted in Figure 3-12, both NE and OT, on their own, were able to 
significantly stimulate GnRH release from proestrous BH explants above basal control 
levels (P<0.01 for NE, P<0.001 for OT). When used in combination, NE/OT stimulated 
GnRH to a greater extent than either alone, and the increase in GnRH released when the 
two neurotransmitters were used together was synergistic rather than additive. Overall, 
combined NE/OT stimulated GnRH to 12.94 + 3.2 ng/mg protein/ml/hour above basal 
control levels, whereas the sum o f the stimulation of GnRH above basal control levels by 
each neurotransmitter alone was 6.36 + 1.39 ng/mg protein/ml/hour. NOS inhibition 
blocked this synergistic effect (Figure 3-13, PO.OOOl), as did OT receptor antagonism 
(Figure 3-14, P<0.01). These results indicate that the combination of NE/OT works to 
stimulate GnRH from proestrous BH explants by utilizing NO, and that this is driven, at 
least in part, by an OT receptor mediated mechanism.
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Administration of the alpha-1 adrenergic antagonist, prazosin, reduced the level of 
stimulation of GnRH by NE/OT 3.74 ng/mg protein/ml/hour, which is slightly greater 
than the stimulation o f GnRH by NE alone above basal control values (3.11 ng/mg 
protein/ml/hour). The level of stimulation of GnRH by NE/OT in the presence of PRZ 
was not significantly different than that by OT alone, and GnRH stimulation by NE/OT 
above OT alone was reduced 72% by PRZ (Figure 3-15). This result corroborates 
previous findings indicating NE stimulation of GnRH is at least in part due to alpha-1 
adrenergic receptor activation. Alpha-2 adrenergic antagonism by administration of 
yohimbine did not affect the ability of NE/OT to stimulate GnRH release from proestrous 
BH explants (Figure 3-16).
These results indicate that NE and OT act in a synergistic manner to stimulate the 
release of GnRH by an OT receptor mediated mechanism, which appears to involve NO. 
That alpha-1 adrenergic receptor antagonism by prazosin attenuated the NE/OT 
stimulation of GnRH to the level of OT alone and alpha-2 adrenergic antagonism by 
yohimbine had no affect on the NE/OT induced GnRH stimulation indicates NE is 
working at least in part through an alpha- 1 adrenergic receptor mediated mechanism to 
stimulate proestrous GnRH in vitro, and that this mechanism is not directly involved in 
the OT-mediated stimulation of GnRH from proestrous BH explants.
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Figure 3-12. Effect of OT and/or NE on GnRH stimulation from proestrous 
BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10'8M), and/or oxytocin (OT, 10'UM). Column heights 
represent mean GnRH (ng/mg protein/ml/hr) released, and vertical lines 
above the columns denote the S.E.M. N=8 animals for all treatments. *, 
significantly different from all other treatment values (P<0.001).
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Figure 3-13. Effect of NOS antagonism on NE/ OT- induced GnRH release
from proestrous BH
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In vitro release o f GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10"8M), oxytocin (OT, 10"nM), and/or the nitric oxide 
synthesis inhibitor LNAME (10~UM). Column heights represent mean 
GnRH (ng/mg protein/ml/hr) released, and vertical lines above columns 
denote the S.E.M. N=8 for all treatments, *, significantly different from all 
other treatment values (PO.OOl).
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Figure 3-14. Effect of administration of an OT receptor antagonist on
NE/OT stimulation of GnRH from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10'8M), oxytocin (OT, 10'11M), and/or an oxytocin 
receptor antagonist (OTA, 10'6M). Column heights represent mean GnRH 
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the 
S.E.M. N=6-8 animals for all treatments, *, significantly different from all 
other treatment values (PO.OOl).
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Figure 3-15. Effect of alpha-1 adrenergic antagonism on the stimulation of
GnRH from proestrous BH by NE and/or OT
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10'8M), oxytocin (OT, 10'nM), and/or the alpha-1 
adrenergic receptor antagonist prazosin, (PRZ, 10~6M). Column heights 
represent mean GnRH (ng/mg protein/ml/hr) released, and vertical lines 
above columns denote the S.E.M. N=8 animals for all treatments. *, 
significantly different from basal control values (PO.Ol).
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Figure 3-16. Effect o f alpha-2 adrenergic antagonism on GnRH stimulation 
from proestrous BH by NE and/or OT
Control NE/OT NE/OT/ 
YO
Treatment
In vitro release of GnRH from basal hypothalamus (BH) explants obtained at 
1500hrs from normally cycling proestrous female Sprague-Dawley rats. 
GnRH release is in response to buffer alone (control), or buffer containing 
norepinephrine (NE, 10'8M), oxytocin (OT, 10'11M), and/or the alpha-2 
adrenergic receptor antagonist yohimbine (YO, 10'6M). Column heights 
represent mean GnRH (ng/mg protein/ml/hr) released, and vertical lines 
above columns denote the S.E.M. N=9 animals for all treatments. *, 
significantly different from basal control values (P<0.05).
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OT and NE Stimulation of Nitric Oxide: Mechanisms of Action and Similarities to 
GnRH Stimulation
NO has been implicated in the control of GnRH secretion in males following its 
stimulation by NE. In order to determine whether NO synthesis and secretion was 
stimulated from the same proestrous BH explants as were used in the GnRH studies 
presented here, nitrate/nitrite levels were measured using a modified Greiss reaction. 
GnRH secretion levels were also measured in these experiments. In addition to basal 
secretion levels, stimulated levels of NO and GnRH secretion were determined following 
treatment with NE and/or OT. The ability of an OT receptor antagonist to inhibit OT/NE- 
induced secretion of NO from proestrous BH explants was also tested.
In combination, NE/OT stimulated NO release more than either neurotransmitter 
by itself, and stimulated GnRH in a synergistic manner (Figure 3-17). OT receptor 
antagonism attenuated both GnRH and NO release in response to combined NE/OT 
(Figure 3-18). Figure 3-19 shows a comparison of the effect of NE, OT, and NE/OT on 
both GnRH and NO in the same animals. These results support the hypothesis that 
NE/OT utilizes NO and an OT receptor-mediated mechanism in order to stimulate GnRH 
release on the afternoon o f proestrus.
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Figure 3-17. Effect of NE and/or OT on NO synthesis in proestrous BH
400i *
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In vitro release of nitric oxide (NO), as measured by percent change in 
nitrite/nitrate levels versus basal (control), from proestrous basal 
hypothalamus (BH) explants obtained at 1500hrs from normally cycling 
female Sprague-Dawley rats. NO release is in response to buffer alone 
(control), or buffer containing norepinephrine (NE, 10'8M), and/or oxytocin 
(OT, 10'hM). Column heights represent mean percent change from basal 
secretion levels (1.57 ug/ml + 0.41), and vertical lines above columns 
indicate the S.E.M. N=6-8 animals for all treatments, **, significantly 
different from basal control (P<0.01) using raw data.
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Figure 3-18. Effect of addition of an OT- receptor antagonist on stimulation 
o f NO synthesis by NE, and/or OT from proestrous BH
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In vitro release of nitric oxide (NO), as measured by percent change in 
nitrite/nitrate levels vs basal (control), from proestrous basal hypothalamus 
(BH) explants obtained at 1500hrs from normally cycling female Sprague- 
Dawley rats. NO release is in response to buffer alone (control), or buffer 
containing norepinephrine (NE, 10'8M), oxytocin (OT, 10'nM), and/or an 
oxytocin receptor antagonist (OTA, 10‘6M). Column heights represent mean 
percent change from basal secretion levels (1.6 ± 0.41 ug/ml), and vertical 
lines above columns indicate the S.E.M. N=6-8 animals for all treatments, 
**, significant compared to basal (P<0.01) using raw data.
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Figure 3-19. Comparison o f NO and GnRH Stimulation in Proestrous BH
Control NE/OT
Control NE OT NE/OT
Treatment
Treatment
Comparison of in vitro stimulation o f GnRH and nitrate/nitrite (NO) 
synthesis from proestrous basal hypothalamus (BH) harvested at 1500hrs 
from normally cycling female Sprague-Dawley rats.
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Effect Of OT. NE, and NE/OT On GnRH and NO Release From Diestrous and 
Estrous BH Explants
Whether there is a difference between the ability o f OT and/or NE to stimulate 
GnRH and NO release from BH explants harvested on the afternoon estrus and diestrus 
versus proestrus was tested. As shown in Figure 3-20, OT and/or NE, stimulated GnRH 
release from diestrous and estrous BH in vitro, but in a different manner than seen on 
proestrus. On estrus (Figure 3-20A), NE and OT stimulated GnRH at levels near those 
seen on proestrous, but the combination of NE/OT stimulated GnRH significantly less 
than seen on proestrus. On diestrus, NE stimulated GnRH more than on either proestrus 
or estrus. OT stimulated GnRH on diestrus, but less than on proestrus or estrus. The 
combination of NE/OT stimulated GnRH on diestrus to about the same level as NE did, 
and to a significantly lesser degree than on proestrus. Thus, though NE and OT are 
capable of stimulating GnRH release on diestrus, estrus, or proestrus, the magnitude of 
these responses is altered the and synergism seen on proestrus is absent during other 
phases of the estrous cycle.
Figure 3-21 depicts OT-, NE-, and OT/NE- induced stimulation of NO on estrus 
or diestrus versus proestrus. NE stimulated NO synthesis significantly more on estrus 
than on diestrus or proestrus. OT had no effect on NO stimulation on estrus, and NE/OT 
combined stimulated NO to about the same level as NE. On diestrous, neither NE, OT, 
nor a combination of the two significantly stimulated NO synthesis. Table 3-1 
summarizes the data for both GnRH and NO stimulation by NE and/or OT on proestrus, 
estrus, and diestrus.
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These results indicate that NE, OT, and their combination differ in their ability to 
stimulate GnRH release and NO synthesis on each day of the estrous cycle. The most 
obvious differences are that the combination of NE/OT stimulates much more GnRH 
release and NO synthesis on proestrus than diestrus or estrus, that NE stimulates GnRH 
release more on diestrus than on any other day of the cycle, and that OT is capable of 
stimulating GnRH release from the BH to some extent on all days of the cycle. Although 
OT’s greatest influence, and its synergism with NE, is seen only on the afternoon of 
proestrus, the ability o f OT and/or NE to stimulate NO and GnRH release appears to be 
modulated by other factors, which may include plasma estradiol and progesterone levels.
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A. Estrous GnRH Release B. Diestrous GnRH Release
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Figure 3-20. Comparison of the ability of oxytocin (OT, 10'nM), 
norepinephrine (NE, 10~8M), and OT/NE combined to stimulate GnRH from 
estrous, diestrous, and proestrous basal hypothalamus (BH) explants 
harvested at 1500hrs from normally cycling Sprague-Dawley rats. Column 
heights represent mean GnRH, bars above columns represents the SEM. 
N=6-8 animals for each treatment group. *, significantly different all other 
treatment groups.
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A. Estrous NO Synthesis B. Diestrous NO Synthesis
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Figure 3-21. A comparison of the stimulation o f nitrate/nitrite (NO) 
synthesis and release from BH explants by oxytocin (OT, 10‘nM) and/or 
norepinephrine (NE, 10'8M), on the afternoons o f estrus, diestrus, or 
proestrus.
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Table 3-1. GnRH and NO stimulation from BH explants by NE and/or OT on the 
afternoons of proestrus, estrus, or diestrus.
GnRH (ng/m g protein /m l/hour)
P ro e s tru s  E stru s D iestru s
Control 1.90 + 0.47 1.76 + 0.36 1.552 + 0.62
NE 4.24 + 0.68 2.98 + 1.0 10.04 + 5.02
OT 5.92 + 0.71 5.58 + 0.39 5.29 + 1.45
NE/OT 14.84 + 3.20 7.42 + 2.14 8 .52+ 1 .50
N itrites/N itrates (ug/ml) 
P ro e s tru s E stru s D iestru s
Control 1.57 + 0.41 1.7 + 0.52 1.72 + 0.40
NE 1.8 + 0.26 2.40 + 0.44 2.23 + 0.7
OT 2.38 + 0.38 1.72 + 0.36 2.10 + 1.17
NE/OT 3.65 + 0.98 2.2  +  0.21 1.88 + 0.75
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Chapter 4: Discussion
Although many important factors involved in the generation o f the proestrous 
GnRH surge and ovulation have been elucidated, the exact neural mechanisms 
controlling this phenomenon remain undetermined. For instance, it has been known for 
some time that in mammals, the ovaries communicate the readiness o f the peripheral 
reproductive system for ovulation to the brain through the secretion o f estradiol and 
progesterone. The CNS then responds to this hormonal information by releasing a large 
pulse of GnRH on the afternoon o f proestrus. This in turn causes LH to be secreted from 
the pituitary into the peripheral circulation, ultimately resulting in ovulation at the 
ovaries. However, it has proven difficult to localize estradiol and progesterone receptors 
on GnRH neurons, indicating that there is involvement of other neural systems in 
“sensing” the hormonal messages from the ovaries. Indeed, many neurotransmitter 
systems have been implicated in the CNS control of female fertility cycles (see Table 1- 
1). However, no single neurotransmitter system, or combination o f transmitter systems, 
has been shown to entirely account for the initiation and propagation of the large 
preovulatory, proestrous GnRH surge. Thus, despite decades of effort by researchers and 
clinicians, the CNS mechanisms involved in female reproductive cycles remain 
unelucidated.
As outlined in the introduction section, the research for this dissertation focused 
primarily on three neurotransmitter systems that have been previously implicated in 
stimulating the preovulatory GnRH surge: NE, OT, and NO. The results o f these studies
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are discussed below, and a model of the mechanisms of interaction between the three 
systems is proposed, along with ideas for future work in this field.
Stimulation Of Proestrous GnRH and NO Release
Previous research indicated a role for central OT in the preovulatory, proestrous 
LH surge (Johnston et al. 1992). However, whether this effect was due to stimulation of 
the hypothalamic hormone responsible for stimulating LH release, GnRH, or because of 
some other, non-physiological effect central OT might have on other neuroendocrine 
regulators of LH secretion was unknown. The present results demonstrate that OT 
stimulated GnRH release from proestrous BH explants, but not ME fragments, where 
GnRH nerve terminals reside. This stimulation occurred at concentrations as low as 10" 
13M, and appeared to peak by 10"9M. Thus, the data suggest that the neuroanatomical and 
neurochemical connectivity present within the intact BH, which includes the ME (where 
GnRH nerve terminals reside), are both necessary and sufficient for very low doses of OT 
to stimulate GnRH release on the afternoon of proestrus.
These initial findings lead to a variety of mechanistic hypotheses concerning OT’s 
stimulatory influence on proestrous GnRH release. One possibility is that OT may 
directly stimulate GnRH release from proestrous BH by stimulating OT receptors located 
somewhere on the GnRH neuron, itself. However, OT- receptors have not been clearly 
demonstrated on GnRH neurons, leaving the likelihood that the stimulatory effect of OT 
on proestrous GnRH release is mediated through some other neural mechanism. As the 
BH contains a very large number of neurotransmitter phenotypes, there are a variety of
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possible intermediaries through which OT may work to stimulate proestrous GnRH 
release. The most obvious candidates include other central neurotransmitters implicated 
in the stimulation of proestrous GnRH release, especially NE, which has been shown to 
be involved in both the tonic and pulsatile regulation of GnRH secretion (Legan and 
Callahan 1999; Gallo 1980). Further, NE and OT have been demonstrated to interact in 
the stimulation of GnRH release in males (Rettori et al. 1977), so the possibility that they 
also do so in females should be considered. Other possible neurotransmitters OT might 
work through to stimulate GnRH from proestrous BH explants include glutamate, which 
has been shown to stimulate GnRH release from the ME (Mahesh and Brand 1998), and 
NO, which also has been shown to be involved in the stimulation o f proestrous GnRH 
release (Bonavera, Kalra, and Kalra 1996), as well as OT- mediated GnRH release from 
male MBH tissues (Rettori et al. 1997).
The hypotheses outlined above were addressed in the present research. In order to 
confirm that the exogenously applied OT was working through OT receptors and not 
related receptors such as those for AVP, the ability of a specific OTA to block the OT- 
induced stimulation of GnRH from proestrous BH explants was examined. OTA 
administration completely blocked the OT- induced stimulation o f GnRH release from 
proestrous BH explants. These results agree with in vivo data demonstrating a selective 
ability of OT antagonists, but not AVP antagonists to block the proestrous LH surge 
(Johnston and Negro-Vilar 1988). Thus, OT appears to stimulate proestrous GnRH and 
subsequent LH release through an OT- receptor mediated mechanism.
The ability of NOS inhibition to block the OT- induced stimulation of proestrous 
GnRH was also investigated. Administration of the NOS inhibitor, LNAME, blocked the
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OT- induced stimulation of proestrous GnRH release from BH explants. This result was 
somewhat expected, as OT has been shown to stimulate GnRH release through an NO 
mediated mechanism in males (McCann et al. 1996). Further, NO-ergic neurons have 
been observed near GnRH neurons in the BH (Herbison et al, 1997), and NO has been 
implicated in the release of GnRH at the level o f the SON and the PVN, where OT 
neuron cell bodies are found (Grossman et al. 1994), as well as at the level of the ME 
(Rettori et al. 1997).
Whether OT stimulates proestrous GnRH release by activation of the 
noradrenergic system was examined by testing the ability o f selective pharmacological 
antagonists o f alpha- adrenergic receptors to block OT- induced GnRH release from 
proestrous BH explants. The results demonstrated that selective antagonists of alpha-1 
and alpha-2 adrenergic receptors (PRZ and YO) failed to block the OT- induced 
stimulation o f GnRH release from proestrous BH, indicating that if there is any interplay 
between NE and OT on GnRH release, it is not due to OT stimulating NE neurons to 
release NE and activate alpha- adrenergic receptors. The ability of OT to stimulate GnRH 
release in the presence of a glutamate anatagonist, NBQX (a specific kainate receptor 
antagonist), was also tested. Kainate receptor antagonism did not block the OT- induced 
GnRH stimulation from proestrous BH explants. This indicates that kainate receptors also 
do not mediate OT’s stimulatory effect on proestrous GnRH release.
In summary, the data from these initial OT studies support the hypothesis that OT 
stimulates GnRH release from the BH on the afternoon of proestrus. This event required 
the connectivity found within the entire BH, which contains both GnRH terminals and 
cell bodies, and did not occur at the level of the ME, where only terminals of GnRH
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neurons reside. Further, the OT- induced release o f GnRH was mediated through an OT 
receptor mechanism, as well as through a NOS- mediated mechanism. Kainate, alpha -1 
and alpha-2 adrenergic receptor antagonism did not affect OT- induced stimulation of 
proestrous GnRH release, indicating that OT does not induce GnRH release by 
stimulating glutamate or NE release, and subsequent activation of kainatae or alpha- 
adrenergic receptors.
Having determined that OT stimulates GnRH release from BH explants harvested 
on the afternoon of proestrus, studies to determine the ability o f NE to stimulate GnRH 
release from proestrous BH explants, and the mechanisms involved in this effect, were 
performed. NE (10'6M to 10'10M) stimulated GnRH release from proestrous BH explants 
in vitro in a manner similar to that seen by Nowack and Swerdloff (1985), who found that 
NE stimulated GnRH release effectively in doses higher than 1CT10M. The data here also 
confirm that increasing doses of NE beyond 10'8M only modestly increase the release of 
GnRH from proestrous BH explants, indicating the system is nearly saturated by NE 
levels in this range.
Whether NE- induced stimulation of proestrous GnRH release was mediated by 
alpha- adrenergic receptors, or by downstream stimulation of OT- receptor mediated 
mechanisms was tested. Alpha-1 adrenergic receptor antagonism by PRZ blocked the 
ability of NE to stimulate GnRH inform proestrous BH explants. Alpha-2 adrenergic 
receptor blockade by YO did not influence the NE- induced increase in proestrous GnRH 
release. Finally, OT receptor antagonism attenuated the ability of NE to stimulate GnRH 
release from proestrous BH explants. These results confirm the observation by others that 
NE stimulates GnRH release on the afternoon of proestrus, and that this phenomenon is
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mediated through alpha-1, and not alpha-2, adrenergic receptors (Lee et al, 2000). 
Whether this is a direct effect o f NE on GnRH neurons was not proven by these studies. 
Although NE projections have been shown in close proximity to GnRH neurons (Gallo 
1980), alpha-1 adrenergic receptors have not yet been conclusively shown on GnRH 
neurons. Thus, it would appear that NE, like OT, might be working through some 
downstream mechanism to stimulate GnRH release from the BH on proestrus. The data 
here suggest this mechanism could utilize the OT neurotransmitter system, as OT- 
receptor antagonism attenuated the ability of NE to stimulate GnRH release from 
proestrous BH explants. This hypothesized NE- induced OT release and subsequent OT 
receptor activation could occur at the level of the PVN or SON, where NE projections are 
sent and OT cell bodies are found (Daftary et al. 1998; Sawyer and Clifton 1980). The 
result that OT receptor antagonism attenuated but did not entirely block NE- induced 
GnRH release was not surprising, as NE has been shown to directly stimulate GnRH 
release from ME explants in males in vitro (Contijoch, Johnson and Advis 1990), and the 
ME is target of an adrenergic projection originating in the locus ceruleus (Adler et al. 
1983).
Because recent literature has indicated that there might be interactions between 
the NE- and OT-ergic systems that could play an important role in the generation of the 
preovulatory, proestrous GnRH surge, the interplay between these two neurotransmitter 
systems in the stimulation o f GnRH from proestrous BH explants was examined. In 
combination, NE/OT stimulated GnRH release from proestrous BH explants 
synergistically rather than additively. This represents the first demonstration of this 
synergistic effect between OT and NE on GnRH release.
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The mechanisms o f this synergism were investigated. Alpha-1 adrenergic receptor 
antagonism by PRZ reduced NE/OT- induced proestrous GnRH release to a level similar 
to that seen with OT alone. Alpha-2 adrenergic receptor antagonism by YO did not affect 
NE/OT- stimulation of GnRH release from proestrous BH. Administration o f a selective 
OTA blocked proestrous GnRH stimulation by NE/OT. Finally, the NE/OT- induced 
release o f GnRH from proestrous BH explants also was blocked by inhibition o f NOS via 
administration o f the NOS antagonist, LNAME.
Since the synergistic effect of NE/OT on stimulation o f GnRH release from 
proestrous BH explants was blocked by both an OT receptor antagonist, and a NOS 
inhibitor, the most important conclusion to be drawn from the present data is that NE and 
OT work through alpha-1 adrenergic and OT- receptor mediated mechanisms, 
respectively, as well as through a NOS mediated mechanism, in order to synergistically 
stimulate proestrous GnRH release. Taking into account the effect o f an OTA on NE- 
induced stimulation of GnRH release from proestrous BH, it seems that part of this 
synergism might be due to NE facilitating OT release, and subsequent stimulation of OT 
receptors in the BH in order to stimulate GnRH release. Whether this is a direct effect of 
NE on OT neurons, or if  another mediating factor is involved cannot be concluded from 
the present data. However, the data does confirm the hypothesis that at least part of the 
synergism by OT and NE in stimulating GnRH release is through an alpha-1 adrenergic 
receptor mediated mechanism, and not an alpha-2  adrenergic receptor mediated 
mechanism.
That the doses of NE and OT which synergistically stimulated GnRH release from 
proestrous BH explants were near the maximal effective dose for each transmitter alone
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
74
(as determined by the dose-response curves) suggests that another neural intermediary 
must be involved in the effect. That NO might be this intermediary responsible for the 
synergistic effect is not surprising. Both NE and OT have been implicated in 
hypothalamic NO stimulation (Rettori et al. 1997, Canteros et al. 1996), and NO has been 
shown to be involved in the preovulatory, proestrous GnRH surge (McCaan et al. 1999). 
NO is a diffusible gas neurotransmitter with a potentially wide target area. This fact, 
when viewed in combination with the sparse numbers and wide distribution of GnRH 
neurons, gives rise to the intriguing possibility that NO may be the chief signaling agent 
for the stimulation of proestrous GnRH release. Further, NOS activity is stimulated by 
both NE and OT, and has been linked to GnRH stimulation on proestrus (McCann et al. 
1998). A plausible hypothesis supported by the current data is that following stimulation 
o f NOS by NE and OT, the resultant NO diffuses and recruits the widely scattered, and 
few in number, GnRH neurons to release GnRH in a coordinated fashion, ultimately 
causing in the large preovulatory GnRH surge which results in the LH surge late in 
proestrus, causing ovulation. Previous studies which have concentrated on single 
neurotransmitter systems, including NE or OT, have been unable to reproduce the 
magnitude of GnRH or LH surges observed on proestrus in the normally cycling female 
rat. The present results suggest that this may have been the result of missing the 
synergism demonstrated here for OT/ NE- induced stimulation of GnRH release.
To summarize the data regarding proestrous GnRH release, OT and NE, alone, 
stimulate proestrous GnRH from proestrous BH explants. When used in combination, this 
stimulation of GnRH from proestrous BH explants is synergistic. This effect is blocked 
by OT receptor antagonism, as well as by inhibition of NOS. Alpha-1 adrenergic
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receptor antagonism decreased the NE/OT- induced stimulation o f GnRH somewhat, 
indicating a removal o f the NE contribution in stimulating GnRH, whereas alpha-2 
adrenergic receptor antagonism had no effect. NE and OT synergistically stimulate 
GnRH via a NO mediated mechanism, which is activated in a synergistic manner by an 
alpha- adrenergic and OT receptor mediated mechanism, respectively.
The ability o f NE and OT to stimulate NO from the same BH tissues used in 
GnRH experiments was tested. Both NE and OT also stimulated NO from proestrous BH 
explants beyond basal control levels in vitro. In combination, they stimulated NO in a 
manner which appeared additive. Stimulation of NO by NE/OT was attenuated by 
addition of an OT receptor antagonist. Due to limitation of the assay used, it was not 
possible to accurately test whether NOS inhibition by LNAME blocked the effect of 
NE/OT on NO stimulation, nor whether NE alpha- adrenergic antagonism blocked the 
effect. Unfortunately, the assay records these compounds as false positives.
The stimulation of NO synthesis and release in response to OT and/or NE 
reported here could occur in a variety of hypothalamic areas, including the ME, where 
there is a rich plexus of NOS-containing neurons (Canteros et al 1996), in other 
hypothalamic areas where NOS- positive and GnRH neurons are found, or in OT neurons 
and NE projections. The two main areas where this overlap occurs are the PVN and SON 
(Hatakeyama et al. 1996). Future studies will be designed to determine where this NOS 
activation occurs in response to NE and/or OT, and on what neuronal processes these 
effects are mediated.
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Stimulation of GnRH and NO on Estrus and Diestrus
The ability o f OT and/or NE to stimulate GnRH and N O  synthesis and release 
from BH explants harvested on the afternoon of estrus and diestrus was also examined. 
On estrus, OT or NE alone stimulated GnRH release in a manner similar to that seen on 
proestrus. However, OT/NE- induced stimulation of GnRH release from estrous BH was 
additive, and the level o f GnRH released was only about half o f  that seen on proestrus. 
Estrous NO secretion was stimulated somewhat by NE, but not OT. NE/OT- induced NO 
synthesis was equal to that by NE alone, indicating that OT does not stimulate NOS- 
containing neurons to produce NO on estrus.
These results were not surprising, as estradiol and progesterone levels remain 
somewhat elevated throughout the earlier part of estrus, and this hormonal input could 
stimulate the NE and OT systems to be partially primed for inducing GnRH release. That 
the synergistic effect o f NE/OT on GnRH release from BH explants was not seen on 
estrus suggests that in order to stimulate GnRH release, all three neurotransmitter systems 
need to be primed for this event, as they are only on the afternoon o f proestrus. That OT 
did not stimulate NO from BH explants harvested on estrus, and <iid not contribute to the 
stimulation of NO when used in combination with NE, suggests that the key to the 
synergism between NE and OT on stimulation of proestrous GnRH release lies in their 
ability to jointly stimulate proestrous NO secretion. This hypothesis is supported by the 
results from diestrous BH explants as well (below).
On diestrus, NE- induced stimulation of GnRH release that was, on average, 
greater than on estrus or proestrus. The reason for this probably lies in the fact that NE is
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involved in the tonic regulation o f GnRH secretion, and thus the noradrenergic receptor 
system remains primed to stimulate GnRH release at any time during the estrous cycle if 
enough NE is available, as it is when the neurotransmitter is exogenously applied as in 
these experiments. OT also stimulated some GnRH release on diestrus, but not as 
significantly above basal levels as it did on estrus or proestrus. In combination, NE/OT 
stimulated GnRH release from diestrous BH explants to an even lesser extent than NE 
alone (although it should be noted that there was a large amount of variability in levels of 
NE- induced GnRH release on diestrus), indicating again that a central component 
involved in the stimulation of GnRH release on proestrus is not at work on other days of 
the cycle. This component appears to be NO, as NE and/or OT did not significantly 
stimulate NO release from diestrous BH explants. This finding provides further proof that 
the key to the synergism between NE and OT in stimulating GnRH release from 
proestrous BH explants is the stimulation of NO.
Model of Mechanisms of Action of NE and OT on the Stimulation of GnRH
Since receptors for neither OT nor NE have been conclusively localized directly 
on GnRH neurons, the research presented here examined the intermediary mechanisms 
by which NE and/or OT stimulate GnRH release from BH explants harvested on the 
afternoon of proestrous. The present data indicate that NE- and OT- stimulation of 
proestrous GnRH is at least in part due to stimulation of NO. Further, NE alpha-1 
adrenergic receptor activation was shown to be integral for the NE- induced stimulation
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of GnRH. OT receptor activation is also necessary for both NE- and OT- induced 
stimulation of GnRH release from proestrous BH explants.
A possible model of the mechanism(s) by which NE and OT synergistically 
stimulate GnRH release has been developed based upon both the present results and 
previous studies, and is presented in Figure 4-1. In this model, both NE and OT influence 
proestrous GnRH release by directly stimulating NO- ergic neurons through activation of 
alpha- adrenergic and OT receptors, respectively. This, in turn, causes the release NO. 
This NO then diffuses throughout the BH and reaches GnRH neuron processes. 
Following activation o f guanylyl cyclase and the subsequent formation of cyclic GMP, 
GnRH neurons in the BH are stimulated to release their contents in a coordinated, 
synchronized fashion from the ME. Other contingencies touched upon in the model 
include a noradrenergic stimulation of OT neurotransmission on the afternoon of 
proestrous, when endogenous hypothalamic OT levels are at their peak (Sarkar, 
Frautschy and Mitsugi 1992). This phenomenon would thereby increase the amount of 
OT- stimulated NO. OT levels are then postulated to be further increased by stimulation 
of a positive feedback loop, whereby OT stimulates it’s own release even further to cause 
an additional positive influence on the system at the proper time of the reproductive 
cycle. Evidence for such an OT- positive feedback system exists (Moos et al. 1998; 
Chevaleyre et al. 2000), but its relevance to proestrous GnRH release has not been 
examined.
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Future Directions
It is said that valuable research creates more questions than it answers. There are 
several questions this research has created regarding the roles of NE, OT, and NO in the 
induction of the preovulatory, proestrous GnRH surge. Among these is whether OT and 
NE would have the same effect on GnRH and LH release in vivo as they do in vitro. 
Further, the data does not address, beyond eliminating the ME as the site of action of OT 
on GnRH release, the anatomical loci of the events described by the biochemical data 
presented here. Thus, to further examine the way these central neurotransmitters interact 
to affect GnRH release on the afternoon of proestrus, a number of different avenues of 
research could be pursued. These should include a variety of in vivo and in vitro 
anatomical and biochemical studies.
In vivo studies of interest would include determining whether the synergistic 
effect of OT/NE on GnRH release seen in vitro also caused a synergistic effect on LH 
release from live, normally cycling female rats. To perform these studies, animals would 
be fitted with ICV cannulae, and OT, NE, or a combination thereof injected into the third 
ventricle on the afternoon o f proestrus, prior to the endogenous GnRH and LH surges. 
Subsequent LH release would then be measured from blood plasma taken during a time 
course following the injection. Further, the ability of centrally administered OTA and 
LNAME to attenuated the synergistic effect of OT and NE on LH release could be 
determined using a similar protocol. Such a study could help prove whether OT and NE 
exert a similar effect on reproductive-specific hormonal release in vivo as they do in 
vitro, with the endpoint to be measured being LH release rather than GnRH. Of course,
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as with any study where agents with more than one potential set of targets are injected 
into the intact brain, other neural mechanisms that might indirectly, and non- 
physiologically effect, LH release might be stimulated by NE and/or OT, and these would 
have to be considered when analyzing the results.
In order to determine the neuroanatomical loci involved in the OT and/or NE 
effects on proestrous GnRH release, ICC studies could be performed to determine where 
in the BH NE and OT might stimulate GnRH neurons on the afternoon of proestrus, and 
what other neurotransmitters or relevant gene transcription products are associated with 
the phenomenon. Since GnRH synthesis and release in the female rat is linked to 
increased transcription of IEGs such as Fos and Jun (Fin, Steiner and Clifton, 1998), 
induction o f these IEGs on proestrus by centrally administered NE and/or OT could be 
visualized using ICC techniques and used as markers o f cell activity in order to determine 
whether the combination o f NE/OT stimulate Fos and/or Jun in a manner similar to how 
they stimulate proestrous GnRH and NO synthesis and release. The results of these 
studies would tell both whether OT and NE synergistically stimulate Fos in the same 
fashion as GnRH, and, perhaps more importantly in an anatomical sense, where in the 
brain this stimulation occurs. If significantly increased levels of Fos induction were 
found, the ability of NOS inhibition, alpha-1 adrenergic and/or OT receptor antagonism 
on its induction could then be ascertained to discover whether there is an easily visualized 
anatomical basis for the biochemical results presented here.
Several other anatomical localization studies could also be performed in order to 
further examine the roles o f OT, NE, and NO in the generation of the preovulatory GnRH 
surge. For instance, co-localization studies could be performed in order to ascertain
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whether alpha-1 adrenergic receptors, and/or OT receptors are found on neurons 
expressing NOS in hypothalamic areas known to contain GnRH neurons, as well as 
examining where in the BH the increases in NO production occur in response to NE 
and/or OT. Studies to determine whether neurons that demonstrated a 15-fold increase in 
OT- receptor message expression on the afternoon o f proestrus (Bale et al. 1996) also 
express GnRH, OT or NE neurons could also be performed. Also of interest would be 
whether alpha adrenergic receptors are found on OT-ergic neurons, since the data 
presented here suggests that part of NE effect on proestrous GnRH release is mediated 
via NE stimulation o f OT, which in turn stimulates the OT receptor. Another important 
question to be addressed is which of the subtypes o f estrogen receptors, estrogen alpha or 
estrogen beta (Laflamme et al. 1998), mediate the changes seen in NE concentrations, as 
well as OT and OT- receptor synthesis, on proestrus in the BH. This could potentially 
help delineate how OT and NE neurons sense the hormonal messages sent by the ovaries 
that indicate time is right for ovulation.
Another question that could be addressed by future experimentation is whether 
NE/OT stimulation o f proestrous GnRH release is accompanied by increases in 2nd 
messenger systems associated with NO and/or other agents implicated in the release o f 
GnRH. For example, the question of whether cGMP levels are increased by treatment 
with NE/OT to proestrous BH tissues could be examined via biochemical assay. Also, 
whether inhibitors o f the formation of cGMP can block the OT/NE effect on proestrous 
GnRH release could be examined. Finally, as GnRH synthesis and release is linked to 
increases in intracellular calcium levels following stimulation of the IP3/DAG system, 
the effect o f inhibitors o f this system on the NE and/or OT-induced stimulation of GnRH
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from proestrous explants and the effect of OT/NE administration on its formation could 
be assessed.
Summary and Conclusions
In summary, the data demonstrated that OT (10'9M to 10'13M) stimulated GnRH 
release in vitro from BH, and not the ME explants, on the afternoon of proestrus in 
normally cycling female rats. This effect was mediated by an OT- receptor mediated 
mechanism, and likely used NO synthesis and release to affect GnRH release. The effect 
of OT on GnRH did not appear to be mediated by kainate or adrenergic receptor- 
mediated mechanisms. NE (10'6M to 10*IOM) also stimulated the release of GnRH from 
proestrous BH explants, through an alpha-1 adrenergic receptor mediated mechanism. In 
combination, NE and OT stimulated GnRH release from proestrous BH explants in a 
synergistic manner. This synergism was mediated by an NO synthesis mechanism and 
involved the stimulation o f both OT and alpha-1 adrenergic receptors. Both NE and OT 
also stimulated NO synthesis, as measured by nitrate/nitrite production, on the afternoon 
of proestrus in normally cycling female rats. Together, NE and OT stimulated proestrous 
NO release in an additive manner. This stimulation was mediated, at least in part, through 
an OT- receptor mediated mechanism.
In conclusion, the synergistic stimulation of GnRH release from proestrous BH 
explants by OT and NE was due to OT and alpha-1 adrenergic receptor stimulation, 
respectively, and the consequent production of NO. Together, these events may explain
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the role that OT plays in the generation o f the proestrous GnRH and LH surges that result 
in ovulation on the afternoon of proestrous in the cycling female rat.
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Figure 4-1. Model of the events hypothesized to be involved in the generation of the 
proestrous GnRH surge. In the model, increasing estradiol and progesterone (E/P) levels 
being secreted from the ovaries are sensed by norepinephrine (NE) and oxytocin (OT) 
neurons in the brain. This results in increased secretion of OT and NE. NE secretion 
further increases the amount o f OT produced, as well as stimulating gonadotropin- 
releasing hormone (GnRH) at the median eminence. Both NE and OT stimulate nitric 
oxide production, which further stimulates the release of GnRH and coordinates that 
secretion to produce the larve preovulatory surge of GnRH. This ultimately results in the 
release of the preovulatory surge o f luteinizing hormone (LH) from the pituitary, causing 
ovulation.
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